Yield10 Bioscience, Inc. (YTEN)
NASDAQ: YTEN · IEX Real-Time Price · USD
0.222
-0.017 (-7.20%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Yield10 Bioscience Revenue
In the year 2023, Yield10 Bioscience had annual revenue of $60.00K, a decrease of -86.67%.
Revenue (ttm)
$60.00K
Revenue Growth
-86.67%
P/S Ratio
56.93
Revenue / Employee
$2,069
Employees
29
Market Cap
3.42M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 60.00K | -390.00K | -86.67% |
Dec 31, 2022 | 450.00K | -164.00K | -26.71% |
Dec 31, 2021 | 614.00K | -185.00K | -23.15% |
Dec 31, 2020 | 799.00K | -7.00K | -0.87% |
Dec 31, 2019 | 806.00K | 250.00K | 44.96% |
Dec 31, 2018 | 556.00K | -388.00K | -41.10% |
Dec 31, 2017 | 944.00K | -215.00K | -18.55% |
Dec 31, 2016 | 1.16M | -191.00K | -14.15% |
Dec 31, 2015 | 1.35M | -1.45M | -51.79% |
Dec 31, 2014 | 2.80M | -978.00K | -25.89% |
Dec 31, 2013 | 3.78M | -37.60M | -90.87% |
Dec 31, 2012 | 41.38M | 39.96M | 2,803.93% |
Dec 31, 2011 | 1.43M | 977.00K | 218.08% |
Dec 31, 2010 | 448.00K | -977.00K | -68.56% |
Dec 31, 2009 | 1.43M | -130.00K | -8.36% |
Dec 31, 2008 | 1.56M | -128.00K | -7.61% |
Dec 31, 2007 | 1.68M | -2.91M | -63.33% |
Dec 31, 2006 | 4.59M | 1.81M | 65.05% |
Dec 31, 2005 | 2.78M | -897.00K | -24.39% |
Dec 31, 2004 | 3.68M | 1.29M | 54.33% |
Dec 31, 2003 | 2.38M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
IT Tech Packaging | 86.55M |
CN Energy Group. | 57.90M |
Golden Minerals Company | 12.00M |
ReTo Eco-Solutions | 4.82M |
SenesTech | 1.19M |
N2OFF | 263.45K |
YTEN News
- 26 days ago - Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 4 weeks ago - Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024 - GlobeNewsWire
- 4 weeks ago - Yield10 Bioscience Announces that the Plant Biosafety Office of the Canadian Food Inspection Agency has Cleared Genome-edited E3902 Camelina for Planting in Canada - GlobeNewsWire
- 5 weeks ago - USDA-APHIS Determines that Yield10 Bioscience's Omega-3 Camelina Varieties May Be Planted and Bred in the United States - GlobeNewsWire
- 2 months ago - Yield10 Bioscience Reports that Proprietary Varieties of Winter Camelina Show Tolerance to Commonly Used Herbicides in First Field Tests - GlobeNewsWire
- 2 months ago - Yield10 Bioscience Grants Global License to VISION Bioenergy Oilseeds for Herbicide Tolerant Camelina Cultivated for the Production of Biofuel Feedstock - GlobeNewsWire
- 2 months ago - Yield10 Bioscience Provides an Update on its Omega-3 Camelina Program - GlobeNewsWire
- 3 months ago - Yield10 Bioscience Files Request for Regulatory Status Review with USDA-APHIS for Camelina Designed to Produce the EPA and DHA Components of Omega-3 Oil - GlobeNewsWire